News Releases

Email Alerts

Jun 8, 2017

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J., June 08, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
May 15, 2017

Insmed Announces Key Additions to its Executive Management Team

Paolo Tombesi named as Chief Financial Officer

BRIDGEWATER, N.J., May 15, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
May 3, 2017

Insmed Reports First Quarter 2017 Financial Results and Provides Business Update

Advancing Toward Top-Line Results from CONVERT Study in 2H 2017

BRIDGEWATER, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Apr 27, 2017

Insmed to Present at the Deutsche Bank 42nd Annual Health Care Conference

BRIDGEWATER, N.J., April 27, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, announced...
Apr 26, 2017

Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017

BRIDGEWATER, N.J., April 26, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Feb 28, 2017

Insmed to Present at the Cowen and Company 37th Annual Health Care Conference

BRIDGEWATER, N.J., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, announced...
Feb 23, 2017

Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update

On Track to Report Top-Line Results from CONVERT Study in 2H 2017

BRIDGEWATER, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Feb 16, 2017

Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017

BRIDGEWATER, N.J., Feb. 16, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Feb 14, 2017

Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent

BRIDGEWATER, N.J., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Jan 4, 2017

Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference

BRIDGEWATER, N.J., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...

Show per page